Optain Health, Inc.
About Optain Health, Inc.
Optain Health is a healthcare technology company developing AI-powered oculomics solutions that use retinal imaging to detect eye diseases like diabetic retinopathy, glaucoma, and age-related macular degeneration, as well as systemic conditions such as cardiovascular disease. Its core products include Resolve, a portable robotic retinal camera that captures images without pupil dilation, and Assure, a diagnostic platform integrating AI workflows and teleophthalmology for point-of-care screening. The company was co-created in 2023 by Aegis Ventures with a vision to bring oculomics into primary care, optometry, and health systems. It operates from New York City and maintains optainhealth.com.
- 🔗 Optain Health secures $26 million Series A funding | Eye Care Network - Ophthalmology Times
- 🔗 Optain - 2026 Company Profile, Funding & Competitors - Tracxn
- 🔗 Optain closes $26M Series A funding, accelerates oculomics | Optain posted on the topic | LinkedIn
- 🔗 Optain: Funding, Team & Investors | Startup Intros
- 🔗 Optain Health secures $26M for retinal imaging platform
Investors
Key highlights
- Closed $26M Series A led by Insight Partners with seven U.S. health systems participating.
- Total funding reached $38M across two rounds since 2023.
- Platform combines portable robotic retinal camera with AI and teleophthalmology for non-invasive screening.
- Focuses on oculomics to detect both ocular and systemic diseases at point of care.
- Backed to accelerate U.S. and global deployment in primary care and optometry settings.
Ask StreetZero about Optain Health, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Technology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account